{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:01:25Z","timestamp":1784628085038,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ0903"],"award-info":[{"award-number":["24KJ0903"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25H00430"],"award-info":[{"award-number":["25H00430"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012036","name":"Lotte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60820-3","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:03:20Z","timestamp":1784624600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep behavioral phenotyping reveals novel features in a mouse model of metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1038","volume":"16","author":[{"given":"Naoaki","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Numano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-0796","authenticated-orcid":false,"given":"Takahisa","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"60820_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"60820_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3350\/CMH.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. vol. 31, 32\u201350. (2025). https:\/\/doi.org\/10.3350\/CMH.2024.0431","journal-title":"Clin. Mol. Hepatol. vol"},{"key":"60820_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","author":"S Pouwels","year":"2022","unstructured":"Pouwels, S. et al. Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord. (2022). https:\/\/doi.org\/10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr. Disord"},{"key":"60820_CR4","doi-asserted-by":"crossref","unstructured":"Andrade, L. F. et al. Association of liver disease and chronic pruritus: A case\u2013control study. Liver International 45, (2025).","DOI":"10.1111\/liv.16126"},{"key":"60820_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep4.1541","volume":"4","author":"C Labenz","year":"2020","unstructured":"Labenz, C. et al. Nonalcoholic fatty liver disease increases the risk of anxiety and depression. Hepatol. Commun. 4, 1293\u20131301 (2020).","journal-title":"Hepatol. Commun."},{"key":"60820_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","volume":"24","author":"S Gencturk","year":"2024","unstructured":"Gencturk, S. & Unal, G. Rodent tests of depression and anxiety: Construct validity and translational relevance. Cogn. Affect. Behav. Neurosci. 24, 191\u2013224 (2024).","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"60820_CR7","doi-asserted-by":"crossref","unstructured":"Kobayashi, K. et al. Long-term scratching analysis of mice using machine learning. PNAS Nexus 4, (2025).","DOI":"10.1093\/pnasnexus\/pgaf292"},{"key":"60820_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jphs.2025.09.011","volume":"159","author":"M Kida","year":"2025","unstructured":"Kida, M. et al. Uncovering motor impairments in duchenne muscular dystrophy: 24-hour automated behavioral analysis of DBA\/2\u00a0N-mdx mice. J. Pharmacol. Sci. 159, 283\u2013291 (2025).","journal-title":"J. Pharmacol. Sci."},{"key":"60820_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"60820_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.physbeh.2014.05.032","volume":"135","author":"A Ennaceur","year":"2014","unstructured":"Ennaceur, A. Tests of unconditioned anxiety - Pitfalls and disappointments. Physiol. Behav. vol. 135, 55\u201371. (2014). https:\/\/doi.org\/10.1016\/j.physbeh.2014.05.032","journal-title":"Physiol. Behav. vol"},{"key":"60820_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11418-024-01786-2","volume":"78","author":"K Takano","year":"2024","unstructured":"Takano, K. et al. The protective effects of Ninjin\u2019yoeito against liver steatosis\/fibrosis in a non-alcoholic steatohepatitis model mouse. J. Nat. Med. 78, 514\u2013524 (2024).","journal-title":"J. Nat. Med."},{"key":"60820_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100197","author":"J Linge","year":"2021","unstructured":"Linge, J., Ekstedt, M. & Dahlqvist Leinhard, O. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Rep. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100197 (2021).","journal-title":"JHEP Rep."},{"key":"60820_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/liv.13919","volume":"39","author":"MG Swain","year":"2019","unstructured":"Swain, M. G. & Jones, D. E. J. Fatigue in chronic liver disease: New insights and therapeutic approaches. Liver Int. 39, 6\u201319. (2019). https:\/\/doi.org\/10.1111\/liv.13919","journal-title":"Liver Int."},{"key":"60820_CR14","doi-asserted-by":"crossref","unstructured":"Yu, A. et al. Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis. Front Med. 9, (2022).","DOI":"10.3389\/fmed.2022.881848"},{"key":"60820_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin, K. D. & Zeisel, S. H. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 28, 159\u2013165. (2012). https:\/\/doi.org\/10.1097\/MOG.0b013e32834e7b4b","journal-title":"Curr. Opin. Gastroenterol."},{"key":"60820_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147621","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Metabolic Crosstalk between liver and brain: From diseases to mechanisms. Int. J. Mol. Sci. (2024). https:\/\/doi.org\/10.3390\/ijms25147621","journal-title":"Int. J. Mol. Sci."},{"key":"60820_CR17","doi-asserted-by":"crossref","unstructured":"L\u2019homme, L. et al. Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH. Nat Commun 15, (2024).","DOI":"10.1038\/s41467-024-51078-2"},{"key":"60820_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu, J. Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"60820_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg, H., Moschen, A. R. & Roden, M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 14, 32\u201342. (2017). https:\/\/doi.org\/10.1038\/nrgastro.2016.147","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"60820_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ueg2.12534","volume":"12","author":"R Gallego-Dur\u00e1n","year":"2024","unstructured":"Gallego-Dur\u00e1n, R. et al. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. United Eur. Gastroenterol. J. 12, 1056\u20131068 (2024).","journal-title":"United Eur. Gastroenterol. J."},{"key":"60820_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cmet.2018.04.001","volume":"27","author":"P Song","year":"2018","unstructured":"Song, P. et al. The hormone FGF21 stimulates water drinking in response to ketogenic diet and alcohol. Cell. Metab. 27, 1338\u20131347e4 (2018).","journal-title":"Cell. Metab."},{"key":"60820_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn.2015.8","volume":"17","author":"AV Kalueff","year":"2016","unstructured":"Kalueff, A. V. et al. Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat. Rev. Neurosci. 17, 45\u201359. (2016). https:\/\/doi.org\/10.1038\/nrn.2015.8","journal-title":"Nat. Rev. Neurosci."},{"key":"60820_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0304-3959(01)00275-5","volume":"92","author":"JMA Laird","year":"2001","unstructured":"Laird, J. M. A., Martinez-Caro, L., Garcia-Nicas, E. & Cervero, F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92, 335\u2013342 (2001).","journal-title":"Pain"},{"key":"60820_CR24","doi-asserted-by":"crossref","unstructured":"Younossi, Z. M. et al. Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease. J Clin. Exp. Hepatol 15, (2025).","DOI":"10.1016\/j.jceh.2025.102549"},{"key":"60820_CR25","doi-asserted-by":"crossref","unstructured":"Custodio, R. J. P. et al. 2023 cells MASH western diet cognitive impariment. Cells 2331 (2023).","DOI":"10.3390\/cells12182331"},{"key":"60820_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1661939","author":"A Segala","year":"2025","unstructured":"Segala, A. et al. Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1661939 (2025).","journal-title":"Front. Pharmacol."},{"key":"60820_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady9758","volume":"11","author":"T Cardoso Delgado","year":"2025","unstructured":"Cardoso Delgado, T. et al. Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy. Sci. Adv. 11, 9758 (2025).","journal-title":"Sci. Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60820-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:03:27Z","timestamp":1784624607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60820-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60820-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Naoaki Sakamoto, Takamasa Numano, and Taichi Yamamoto declare that they have no conflict of interest. Yui Kobayashi, Masahiro Fukuda, Maria Osaki, Keisuke Omori and Takahisa Murata are affiliated with an endowed course (Food and Animal Systemics) supported by the Revamp Corporation (Tokyo, Japan). Takahisa Murata has received research grants from LOTTE.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"20769"}}